The U.S. fertility market is estimated to be valued at $8 billion, inclusive of IVF, genetic testing, reproductive issue storage and donor services. IVF services, in particular, comprise a $3 billion market, and such services are projected to grow at a ~10+ CAGR through 2024, The National Law Review reports.
Investors have taken note of the demand and opportunities in the fertility industry. In 2019, investors invested over $624 million in the space, up from $200 million in 2009. Investments have occurred with respect to ART-dedicated clinics, broader womens’ health clinics, fertility benefits companies, wearables and technology providers, lab testing companies, fertility finance companies and tele-fertility providers. Read more.
